DOR BioPharma Announces Initiation of GI Radiation Injury Program Pursuant to $1 Million NIH Grant (Marketwire via Yahoo! Finance) by Allergy and asthma associate

Tue, 25 Sep 2007 07:03:24 -0400

DOR BioPharma Announces Initiation of GI Radiation Injury Program Pursuant to $1 Million NIH Grant (Marketwire via Yahoo! Finance)

by Allergy and asthma associate @ Tue, 25 Sep 2007 07:03:24 -0400
DOR BioPharma, Inc. announced today that its academic partner, the Fred Hutchinson Cancer Research Center, has received a $1 million grant from the National Institute of Health to conduct preclinical studies of oral Beclomethasone Dipropionate for the treatment of gastrointestinal radiation injury.

Mast Cells Play Dual Role in Triggering Symptoms In Allergy Attacks But Also Limiting the Damage (Medical News Today)
A blood cell known as a troublemaker for triggering the itch and inflammation in allergy attacks, the mast cell, can also calm down the flare-ups, researchers from Stanford University School of Medicine have found.The findings, published in the online version of Nature Immunology, reveal that, in mice, mast cells help decrease skin damage over time from sun exposure or from poison oak. [click ...